Danaher (1DHR) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1DHR Analyst Ratings

Strong Buy

17 Buy

2 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Danaher

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1DHR Stock 12 Month Forecast

Average Price Target

€195.87

▲(5.25% Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is €195.87 with a high forecast of €219.48 and a low forecast of €171.19. The average price target represents a 5.25% change from the last price of €186.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"151":"€151","220":"€220","168.25":"€168.3","185.5":"€185.5","202.75":"€202.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":219.4776775,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€219.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":195.87163396444444,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€195.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":171.19258845,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€171.19</span>\n  </div></div>","useHTML":true}}],"tickPositions":[151,168.25,185.5,202.75,220],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,180.6,183.59059057692306,186.58118115384616,189.57177173076923,192.5623623076923,195.5529528846154,198.54354346153846,201.53413403846153,204.52472461538463,207.5153151923077,210.50590576923076,213.49649634615383,216.48708692307693,{"y":219.4776775,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,180.6,181.77474107418803,182.94948214837606,184.1242232225641,185.29896429675213,186.47370537094017,187.6484464451282,188.82318751931624,189.99792859350427,191.1726696676923,192.34741074188034,193.52215181606837,194.6968928902564,{"y":195.87163396444444,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,180.6,179.8763529576923,179.15270591538462,178.4290588730769,177.70541183076924,176.98176478846153,176.25811774615383,175.53447070384615,174.81082366153845,174.08717661923075,173.36352957692307,172.63988253461537,171.9162354923077,{"y":171.19258845,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":174.801,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.46,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.02,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":193.597,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.826,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":184.988,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.25,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":164.69,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.825,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.22,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":168.55,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":180.6,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€219.48

Average Price Target€195.87

Lowest Price Target€171.19

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Joanne Wuensch

Citi

€201.92

Buy

8.50%

Upside

Reiterated

09/21/26

Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR), Argenx Se (NASDAQ: ARGX) and Boston Scientific (NYSE: BSX)

Evie Koslosky

Goldman Sachs

€184.36→€219.48

Buy

17.94%

Upside

Reiterated

09/20/26

Goldman Sachs Sticks to Their Buy Rating for Danaher (DHR)

Tycho Peterson

Jefferies

€184.36

Buy

-0.93%

Downside

Reiterated

09/18/26

Jefferies Sticks to Their Buy Rating for Danaher (DHR)

Doug Schenkel

UBS

€219.48

Buy

17.94%

Upside

Initiated

09/13/26

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT), Scholar Rock Holding (NASDAQ: SRRK) and Danaher (NYSE: DHR)

Luke Sergott

Barclays

€201.92

Buy

8.50%

Upside

Reiterated

08/04/26

Danaher (DHR) Gets a Buy from Barclays

Kallum Titchmarsh

Morgan Stanley

€193.14

Buy

3.78%

Upside

Reiterated

08/03/26

Analysts' Top Healthcare Picks: Danaher (DHR), Vertex Pharmaceuticals (VRTX)

Michael Ryskin

Bank of America Securities

€201.92

Buy

8.50%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK), Rocket Pharmaceuticals (NASDAQ: RCKT) and Danaher (NYSE: DHR)

David Westenberg

Piper Sandler

€175.58

Hold

-5.65%

Downside

Reiterated

07/27/26

Piper Sandler Sticks to Its Hold Rating for Danaher (DHR)

Casey Woodring

J.P. Morgan

€215.09→€193.14

Buy

3.78%

Upside

Reiterated

07/23/26

J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)

David Toung

Argus Research

€201.92

Buy

8.50%

Upside

Assigned

07/23/26

Danaher's recent volatility presents buying opportunity, says ArgusDanaher's recent volatility presents buying opportunity, says Argus

Daniel Brennan

TD Cowen

€210.7→€207.19

Buy

11.33%

Upside

Reiterated

07/22/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF), Danaher (NYSE: DHR) and TransMedics Group (NASDAQ: TMDX)

Brandon Couillard

Wells Fargo

€186.12→€171.19

Hold

-8.01%

Downside

Reiterated

07/22/26

Wells Fargo Remains a Hold on Danaher (DHR)

Matt Larew

William Blair

―

Buy

―

Reiterated

07/22/26

Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Illumina (ILMN)

Daniel Arias

Stifel Nicolaus

€228.26→€193.14

Buy

3.78%

Upside

Reiterated

07/22/26

Danaher price target lowered to $220 from $260 at StifelDanaher price target lowered to $220 from $260 at Stifel

Justin Bowers

Deutsche Bank

€219.48→€210.7

Buy

13.22%

Upside

Assigned

07/22/26

Danaher price target lowered to $240 from $250 at Deutsche BankDanaher price target lowered to $240 from $250 at Deutsche Bank

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Joanne Wuensch

Citi

€201.92

Buy

8.50%

Upside

Reiterated

09/21/26

Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR), Argenx Se (NASDAQ: ARGX) and Boston Scientific (NYSE: BSX)

Evie Koslosky

Goldman Sachs

€184.36→€219.48

Buy

17.94%

Upside

Reiterated

09/20/26

Goldman Sachs Sticks to Their Buy Rating for Danaher (DHR)

Tycho Peterson

Jefferies

€184.36

Buy

-0.93%

Downside

Reiterated

09/18/26

Jefferies Sticks to Their Buy Rating for Danaher (DHR)

Doug Schenkel

UBS

€219.48

Buy

17.94%

Upside

Initiated

09/13/26

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT), Scholar Rock Holding (NASDAQ: SRRK) and Danaher (NYSE: DHR)

Luke Sergott

Barclays

€201.92

Buy

8.50%

Upside

Reiterated

08/04/26

Danaher (DHR) Gets a Buy from Barclays

Kallum Titchmarsh

Morgan Stanley

€193.14

Buy

3.78%

Upside

Reiterated

08/03/26

Analysts' Top Healthcare Picks: Danaher (DHR), Vertex Pharmaceuticals (VRTX)

Michael Ryskin

Bank of America Securities

€201.92

Buy

8.50%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK), Rocket Pharmaceuticals (NASDAQ: RCKT) and Danaher (NYSE: DHR)

David Westenberg

Piper Sandler

€175.58

Hold

-5.65%

Downside

Reiterated

07/27/26

Piper Sandler Sticks to Its Hold Rating for Danaher (DHR)

Casey Woodring

J.P. Morgan

€215.09→€193.14

Buy

3.78%

Upside

Reiterated

07/23/26

J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)

David Toung

Argus Research

€201.92

Buy

8.50%

Upside

Assigned

07/23/26

Danaher's recent volatility presents buying opportunity, says ArgusDanaher's recent volatility presents buying opportunity, says Argus

Daniel Brennan

TD Cowen

€210.7→€207.19

Buy

11.33%

Upside

Reiterated

07/22/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF), Danaher (NYSE: DHR) and TransMedics Group (NASDAQ: TMDX)

Brandon Couillard

Wells Fargo

€186.12→€171.19

Hold

-8.01%

Downside

Reiterated

07/22/26

Wells Fargo Remains a Hold on Danaher (DHR)

Matt Larew

William Blair

―

Buy

―

Reiterated

07/22/26

Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Illumina (ILMN)

Daniel Arias

Stifel Nicolaus

€228.26→€193.14

Buy

3.78%

Upside

Reiterated

07/22/26

Danaher price target lowered to $220 from $260 at StifelDanaher price target lowered to $220 from $260 at Stifel

Justin Bowers

Deutsche Bank

€219.48→€210.7

Buy

13.22%

Upside

Assigned

07/22/26

Danaher price target lowered to $240 from $250 at Deutsche BankDanaher price target lowered to $240 from $250 at Deutsche Bank

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

MDWDMediwound

OVIDOvid Therapeutics

CELCCelcuity

ONCBeOne Medicines

GHGuardant Health

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Danaher

3 Months

Dan LeonardRBC Capital

Success Rate

16/21 ratings generated profit

Average Return

+10.11%

Copying Dan Leonard's trades and holding each position for 3 Months would result in 76.19% of your transactions generating a profit, with an average return of +10.11% per trade.

1 Year

Doug SchenkelUBS

Success Rate

12/14 ratings generated profit

Average Return

+23.85%

Copying Doug Schenkel's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +23.85% per trade.

2 Years

Doug SchenkelUBS

Success Rate

12/14 ratings generated profit

Average Return

+51.36%

Copying Doug Schenkel's trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +51.36% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1DHR Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1DHR has received 28 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 1DHR average Analyst price target in the past 3 months is 195.87.

Each month's total comprises the sum of three months' worth of ratings.

1DHR Financial Forecast

1DHR Earnings Forecast

Next quarter’s earnings estimate for 1DHR is €1.67 with a range of €1.60 to €1.74. The previous quarter’s EPS was €1.70. 1DHR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1DHR has Performed in-line its overall industry.

1DHR Sales Forecast

Next quarter’s sales forecast for 1DHR is €5.73B with a range of €5.63B to €5.83B. The previous quarter’s sales results were €5.48B. 1DHR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1DHR has Performed in-line its overall industry.

1DHR Stock Forecast FAQ

What is IT:1DHR’s average 12-month price target, according to analysts?

Based on analyst ratings, Danaher Corp.’s 12-month average price target is 195.87.

What is IT:1DHR’s upside potential, based on the analysts’ average price target?

Danaher Corp. has 5.25% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Danaher Corp. a Buy, Sell or Hold?

Danaher Corp. has a consensus rating of Strong Buy, which is based on 17 buy ratings, 2 hold ratings and 0 sell ratings.

What is Danaher Corp.’s share price target?

The average share price target for Danaher Corp. is 195.87. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €219.48 ,and the lowest forecast is €171.19. The average share price target represents 5.25% Increase from the current price of €186.1.

What do analysts say about Danaher Corp.?

Danaher Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of Danaher Corp.?

To buy shares of IT:1DHR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Danaher (1DHR) Stock Forecast & Price Target

1DHR Analyst Ratings

1DHR Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Danaher

1DHR Analyst Recommendation Trends

1DHR Financial Forecast

1DHR Earnings Forecast

1DHR Sales Forecast

1DHR Stock Forecast FAQ

Detailed List of Analyst Forecasts